BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7042090)

  • 1. Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.
    Young CW; Straus DJ; Myers J; Passe S; Nisce LZ; Lee BJ; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson BD
    Cancer Treat Rep; 1982 Apr; 66(4):907-14. PubMed ID: 7042090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternating chemotherapy and radiation therapy in the treatment of advanced Hodgkin's disease.
    Grigoraki V; Merle-Beral H; Touboul E; Gabarre J; Lesty C; Binet JL
    Nouv Rev Fr Hematol (1978); 1988; 30(4):219-24. PubMed ID: 3194187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
    Straus DJ; Myers J; Passe S; Young CW; Nisce LZ; Lee BJ; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson BD
    Cancer; 1980 Jul; 46(2):233-40. PubMed ID: 6155987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy?
    Mundt AJ; Connell PP; Mansur DB
    Radiat Oncol Investig; 1999; 7(6):353-9. PubMed ID: 10644058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
    Jenkin D; Chan H; Freedman M; Greenberg M; Gribbin M; McClure P; Saunders F; Sonley M
    Cancer Treat Rep; 1982 Apr; 66(4):949-59. PubMed ID: 7042093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
    Peterson BA; Pajak TF; Cooper MR; Nissen NI; Glidewell OJ; Holland JF; Bloomfield CD; Gottlieb AJ
    Cancer Treat Rep; 1982 Apr; 66(4):889-98. PubMed ID: 7042088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
    Zhou L; Wang Q; Feng F
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):333-5. PubMed ID: 11778565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease in Indian children: outcome with chemotherapy alone.
    Arya LS; Dinand V; Thavaraj V; Bakhshi S; Dawar R; Rath GK; Singh R; Vats TS
    Pediatr Blood Cancer; 2006 Jan; 46(1):26-34. PubMed ID: 16161019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The chemotherapeutic treatment of advanced Hodgkin's disease].
    Epelbaum R; Haim N; Ben-Shahar M; Valtuch I; Faraggi D; Sharabi-Nov A; Ben-Arie Y; Cohen Y
    Harefuah; 2001 Apr; 140(4):311-5, 367. PubMed ID: 11303395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.